Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA GLENMARK PHARMA DISHMAN PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 30.0 -31.4 - View Chart
P/BV x 3.3 2.9 117.1% View Chart
Dividend Yield % 0.7 0.3 254.4%  

Financials

 DISHMAN PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
GLENMARK PHARMA
Mar-23
DISHMAN PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs374487 76.9%   
Low Rs129349 36.9%   
Sales per share (Unadj.) Rs197.0460.4 42.8%  
Earnings per share (Unadj.) Rs21.213.4 158.4%  
Cash flow per share (Unadj.) Rs34.735.0 99.0%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Avg Dividend yield %0.80.6 132.9%  
Book value per share (Unadj.) Rs179.9335.1 53.7%  
Shares outstanding (eoy) m80.70282.17 28.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 140.7%   
Avg P/E ratio x11.931.3 38.0%  
P/CF ratio (eoy) x7.311.9 60.8%  
Price / Book Value ratio x1.41.2 112.2%  
Dividend payout %9.418.7 50.5%   
Avg Mkt Cap Rs m20,307117,953 17.2%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35527,810 19.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898129,901 12.2%  
Other income Rs m2653,168 8.4%   
Total revenues Rs m16,163133,069 12.1%   
Gross profit Rs m4,10315,125 27.1%  
Depreciation Rs m1,0916,113 17.8%   
Interest Rs m9443,496 27.0%   
Profit before tax Rs m2,3348,685 26.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6244,911 12.7%   
Profit after tax Rs m1,7103,774 45.3%  
Gross profit margin %25.811.6 221.7%  
Effective tax rate %26.756.5 47.3%   
Net profit margin %10.82.9 370.2%  
BALANCE SHEET DATA
Current assets Rs m11,01898,737 11.2%   
Current liabilities Rs m9,51750,455 18.9%   
Net working cap to sales %9.437.2 25.4%  
Current ratio x1.22.0 59.2%  
Inventory Days Days577 851.1%  
Debtors Days Days3115 3.0%  
Net fixed assets Rs m18,78776,920 24.4%   
Share capital Rs m161282 57.2%   
"Free" reserves Rs m14,35494,281 15.2%   
Net worth Rs m14,51694,563 15.4%   
Long term debt Rs m4,18938,521 10.9%   
Total assets Rs m29,805175,658 17.0%  
Interest coverage x3.53.5 99.6%   
Debt to equity ratio x0.30.4 70.8%  
Sales to assets ratio x0.50.7 72.1%   
Return on assets %8.94.1 215.2%  
Return on equity %11.84.0 295.2%  
Return on capital %17.59.2 191.5%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,95246,464 10.7%   
Fx outflow Rs m69712,712 5.5%   
Net fx Rs m4,25533,751 12.6%   
CASH FLOW
From Operations Rs m2,7866,254 44.6%  
From Investments Rs m-1,529-5,285 28.9%  
From Financial Activity Rs m-941-775 121.5%  
Net Cashflow Rs m317325 97.4%  

Share Holding

Indian Promoters % 61.4 46.7 131.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 34.7 66.2%  
FIIs % 12.0 23.7 50.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 53.4 72.4%  
Shareholders   52,291 209,931 24.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Glenmark Pharma Share Price Performance

Period Dishman Pharma Glenmark Pharma S&P BSE HEALTHCARE
1-Day 2.87% -0.57% 1.18%
1-Month -2.45% 5.16% -0.75%
1-Year 96.38% 112.94% 61.82%
3-Year CAGR 89.34% 27.51% 18.16%
5-Year CAGR 38.20% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.